デフォルト表紙
市場調査レポート
商品コード
1654726

世界の光線療法機器市場-2025-2033年

Global Phototherapy Equipment Market - 2025-2033


出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
世界の光線療法機器市場-2025-2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の光線療法機器市場は、2024年に5億2,121万米ドルに達し、2033年には7億4,652万米ドルに達すると予測され、予測期間2025年にはCAGR 4.8%で成長すると予測されています。

世界の光線療法機器市場には、特定の波長の光を使用して様々な皮膚状態や障害を治療する装置やシステムが含まれます。一般に光線療法または光治療として知られるこの治療法は、乾癬、湿疹、白斑を含む様々な症状に効果的に対処します。

乾癬は、皮膚細胞の急速な増殖を特徴とする慢性の自己免疫疾患であり、その結果、厚く、赤く、うろこ状の斑点が生じる。光線療法は、紫外線を皮膚に照射することにより、過剰な皮膚細胞の産生を抑制し、炎症を抑えることができます。湿疹(アトピー性皮膚炎)は、赤み、かゆみ、炎症を引き起こす炎症性皮膚疾患です。光線療法は、炎症やかゆみを抑えることで、湿疹のある人に有益です。

白斑は、メラノサイトの破壊によって色素が斑状に消失する皮膚疾患です。光線療法、特にナローバンドUVB療法は、患部の色素再形成を促すことができます。新生児黄疸は、血液中のビリルビンの過剰によって引き起こされる新生児によく見られる症状で、皮膚や眼が黄色くなります。光線療法はこの症状に対する標準的な治療法です。光線療法では、皮膚中のビリルビンを分解し、その排泄を促進する特殊な青い光の下に乳児を置く。

世界の光線療法機器市場は、このような症状に対する意識の高まりと光線療法技術の進歩により、大きな成長を遂げています。LEDベースのシステムや光ファイバー機器などのデバイスは、その効果と安全性の特徴から普及が進んでいます。これらの要因が世界の光線療法機器市場拡大の原動力となっています。

市場力学:

促進要因と抑制要因

光線療法技術の革新

世界の光線療法機器市場は現在、光線療法技術の革新に後押しされた大幅な進化を目の当たりにしています。これらの進歩は、治療効果、患者の安全性、光線療法ソリューションへの全体的なアクセスを向上させています。

LEDベースの光線療法機器へのシフトは、市場の重要な動向です。LEDは高効率で耐久性があり、さまざまな皮膚症状の治療に必要な特定の波長の光を照射できます。メンテナンスの必要性が低く、エネルギー消費量が少ないため、従来の蛍光灯よりも好まれ、ヘルスケアプロバイダーの運用コストを下げながら治療結果を向上させます。

在宅ヘルスケアの増加により、患者が自宅で使用できる携帯型光線療法機器の開発に拍車がかかっています。この動向は、新生児黄疸や慢性皮膚疾患など、継続的な治療が不可欠な疾患に特に関連しています。ホームケア・ソリューションは利便性を提供し、通院頻度を減らし、患者がより効果的に病状を管理できるようにします。

例えば、2024年4月、Bestqool社は、家庭で効果的かつ便利に使用できるよう特別に設計されたポータブル赤色光治療器の新ラインを発売しました。これらの機器は赤色光と近赤外光療法を利用し、幅広い健康効果を提供するため、多様な人々が利用できます。

また、2024年6月、ダーマラックスは、ロンドンのコヴェント・ガーデンにあるIceTankで開催された発表会において、革新的なLED光線療法治療システムであるTri-Wave MD MK IIを発表しました。この先進的な装置は、皮膚の広範囲に効果的な光治療を提供するよう特別に設計されており、さまざまな皮膚の状態に適しています。これらすべての要因が、世界の光線療法機器市場に需要をもたらしています。

さらに、スマートテクノロジーの統合に対する需要の高まりも、世界の光線療法機器市場拡大に寄与しています。

また、2024 年 6 月、ダーマラックスは、ロンドンのコベント ガーデンにある IceTank で開催された発表イベント中に、革新的な LED 光線療法治療システムである Tri-Wave MD MK II を発表しました。この高度なデバイスは、広範囲の皮膚領域に効果的な光療法を提供できるように特別に設計されており、さまざまな皮膚の状態に適しています。これらすべての要因が世界の光線療法機器市場を需要しています。

さらに、スマートテクノロジーの統合に対する需要の高まりは、世界の光線治療機器市場の拡大に貢献しています。

治療に伴うリスク要因

UVB療法やPUVA療法に伴う合併症は、患者の安全性や治療の受容性に悪影響を及ぼす可能性があるため、世界の光線療法機器市場では大きな抑制要因となっています。2024年2月の米国立生物工学情報センター(NCBI)のデータによると、UVB療法の急性作用には紅斑や灼熱感が含まれ、これは通常12~24時間以内にピークに達し、皮膚の薄い人や特定の薬剤を服用している人ではより重篤になる可能性があります。

慢性的な合併症は、ブロードバンドUVB療法とナローバンドUVB療法で異なる潜在的な発がん性リスクとともに、乾燥肌、しわ、皮膚の脆弱性の増加を特徴とする光老化を引き起こす可能性があります。また、PUVA療法には、長引く紅斑、吐き気、まれに爪の損傷をもたらす光毒性などの急性リスクもありますが、慢性的な影響としては、PUVA黒子、扁平上皮がんのリスク上昇、眼水晶体へのプソラレン蓄積による白内障開発の可能性があります。したがって、上記の要因が世界の光線療法機器市場の潜在的成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 光線療法技術の革新
    • 抑制要因
      • 治療に関連するリスク要因
    • 機会
    • 影響分析

第5章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名なプレーヤー
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学
  • キーオピニオンリーダー

第6章 製品タイプ別

  • 従来の光線療法機器
    • 全身光線療法機器
    • 部分本文光線療法機器
    • 従来の蛍光灯付き光線療法機器
    • 従来型光線療法機器コンパクト蛍光灯
  • LED光線療法機器
  • ファイバーオプティック光線療法機器
  • 殺菌灯
  • アクセサリー

第7章 放射線の種類別

  • UVA(紫外線A)
  • UVB(紫外線B)
  • UVC(紫外線C)

第8章 用途別

  • 皮膚疾患の治療
    • 乾癬
    • 湿疹
    • 白斑
    • ニキビ
    • その他
  • 新生児黄疸管理

第9章 最終用途別

  • 病院・専門クリニック
  • 皮膚科センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • GE Healthcare
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標(KPI)
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Philips
  • Natus Medical Incorporated
  • Phoenix Medical Systems.
  • Atom Medical Corp.
  • Nice Neotech Medical Systems Pvt. Ltd.
  • NatBio.
  • Solarc Systems Inc.
  • The Daavlin Company
  • MTTS.

第13章 付録

目次
Product Code: MD1626

The global phototherapy equipment market reached US$ 521.21 million in 2024 and is expected to reach US$ 746.52 million by 2033, growing at a CAGR of 4.8 % during the forecast period 2025-2033.

The global phototherapy equipment market includes devices and systems that use specific wavelengths of light to treat various skin conditions and disorders. This medical treatment, commonly known as phototherapy or light therapy, effectively addresses a range of conditions, including psoriasis, eczema, and vitiligo.

Psoriasis is a chronic autoimmune disease characterized by the rapid proliferation of skin cells, resulting in thick, red, and scaly patches. Phototherapy helps manage this condition by exposing the skin to ultraviolet (UV) light, which can slow down the excessive skin cell production and reduce inflammation. Eczema, or atopic dermatitis, is a prevalent inflammatory skin condition that leads to red, itchy, and inflamed skin. Phototherapy can be beneficial for individuals with eczema by reducing inflammation and itching.

Vitiligo is a skin disorder marked by the loss of pigment in patches due to the destruction of melanocytes. Phototherapy, particularly narrowband UVB therapy, can stimulate repigmentation in affected areas. Neonatal jaundice is a common condition in newborns caused by an excess of bilirubin in the blood, leading to yellowing of the skin and eyes. Phototherapy is a standard treatment for this condition; it involves placing the infant under specialized blue lights that help break down bilirubin in the skin, facilitating its excretion.

The global phototherapy equipment market is witnessing significant growth due to increasing awareness of these conditions and advancements in phototherapy technology. Devices such as LED-based systems and fiber-optic equipment are becoming more prevalent due to their effectiveness and safety features. These factors have driven the global phototherapy equipment market expansion.

Market Dynamics: Drivers & Restraints

Innovations in Phototherapy Technology

The global phototherapy equipment market is currently witnessing substantial advancements propelled by innovations in phototherapy technology. These advancements are improving treatment effectiveness, patient safety, and overall accessibility to phototherapy solutions.

The shift towards LED-based phototherapy devices is a significant trend in the market. LEDs offer high efficiency, durability, and the capability to emit specific wavelengths of light necessary for treating various skin conditions. Their low maintenance needs and reduced energy consumption make them preferable over traditional fluorescent lamps, enhancing treatment outcomes while lowering operational costs for healthcare providers.

The rise in home healthcare has spurred the development of portable phototherapy devices that patients can use at home. This trend is particularly relevant for conditions like neonatal jaundice and chronic skin disorders, where continuous treatment is essential. Homecare solutions provide convenience, reduce the frequency of hospital visits, and empower patients to manage their conditions more effectively.

Furthermore, key players in the industry innovative product launches that would drive this global phototherapy equipment market growth.For instance, in April 2024, Bestqool launched a new line of portable red light therapy devices, specifically engineered for effective and convenient use at home. These devices utilize red and near-infrared light therapy to offer a wide range of health benefits, making them accessible to a diverse audience.

Also, in June 2024, Dermalux introduced the Tri-Wave MD MK II, an innovative LED phototherapy treatment system, during a launch event held at IceTank in Covent Garden, London. This advanced device is specifically engineered to deliver effective light therapy over extensive skin areas, making it suitable for a variety of skin conditions. All these factors demand the global phototherapy equipment market.

Moreover, the rising demand for the integration of smart technologies contributes to the global phototherapy equipment market expansion.

Risk Factors Associated with the Treatment

The complications associated with UVB and PUVA therapy present significant restraints in the Global Phototherapy Equipment Market, as they can adversely affect patient safety and treatment acceptance. According to the National Center for Biotechnology Information (NCBI) data in February 2024, acute effects of UVB therapy include erythema and burning sensations, which typically peak within 12 to 24 hours and may be more severe in individuals with lighter skin types or those on certain medications.

Chronic complications can lead to photoaging, characterized by dry skin, wrinkling, and increased skin fragility, alongside potential carcinogenic risks that differ between broadband and narrowband UVB therapies. PUVA therapy also carries acute risks such as phototoxicity, resulting in prolonged erythema, nausea, and rare nail damage, while chronic effects may include PUVA lentigines, an elevated risk of squamous cell carcinoma, and potential cataract development due to psoralen accumulation in the ocular lens. Thus, the above factors could be limiting the global phototherapy equipment market's potential growth.

Segment Analysis

The global phototherapy equipment market is segmented based on product type, radiation type, application, end-user, and region.

Product Type:

The conventional phototherapy equipment segment is expected to dominate the global phototherapy equipment market share

The conventional phototherapy equipment segment holds a major portion of the global phototherapy equipment market share and is expected to continue to hold a significant portion of the global phototherapy equipment market share during the forecast period.

The global phototherapy equipment market includes a diverse range of devices specifically designed for the effective treatment of skin conditions and neonatal jaundice. A significant segment within this market is conventional phototherapy equipment, which can be categorized into several types, including full-body phototherapy equipment, partial-body phototherapy equipment, conventional phototherapy equipment with fluorescent lamps, and conventional phototherapy equipment with compact fluorescent lamps.

Conventional phototherapy equipment primarily utilizes light sources such as fluorescent lamps and compact fluorescent lamps to deliver therapeutic light. These devices are widely utilized in clinical settings due to their proven effectiveness and affordability in treating conditions like psoriasis, eczema, vitiligo, and neonatal jaundice. Their established presence in healthcare facilities highlights their importance in dermatological care.

Conventional phototherapy equipment includes full-body phototherapy equipment, partial-body phototherapy equipment, conventional phototherapy equipment with fluorescent lamps, and conventional phototherapy equipment with compact fluorescent lamps. Full-body phototherapy units are designed to expose the entire body to therapeutic light, making them particularly effective for treating extensive skin conditions or managing neonatal jaundice in infants. Partial-body phototherapy equipment is tailored for localized treatment of specific areas affected by skin conditions.

Conventional phototherapy equipment with fluorescent lamps this category includes devices that utilize traditional fluorescent lamps as their primary light source. Compact fluorescent lamps (CFLs) represent a modern advancement within the conventional phototherapy segment. CFLs are smaller and more energy efficient than traditional fluorescent tubes while producing higher irradiance levels.

Furthermore, key players in the industry have key initiatives and innovative product launches that would propel this segment's growth in the global phototherapy equipment market. For instance, in September 2024, Best Choice Specialist Hospital unveiled the first intensive infant phototherapy machine in Kano, Nigeria. This cutting-edge equipment is specifically designed to effectively treat jaundice in newborns, representing a significant advancement in neonatal care for the region. The introduction of this machine aims to enhance healthcare solutions for infants suffering from jaundice, improving treatment capabilities at the hospital and providing families with better access to essential medical care.

Also, in November 2023, GlobalMed Technologies introduced the Omnilux Mini, a new line of three FDA-cleared LED devices designed for targeted skincare treatments. Each device is distinguished by its flexibility, portability, and affordability, retailing at $95. The Omnilux Mini utilizes red, near-infrared, and blue LEDs to effectively tackle various skin issues, including fine lines, wrinkles, acne, and overall skin health. These factors have solidified the segment's position in the global phototherapy equipment market.

Geographical Analysis

North America is expected to hold a significant position in the global phototherapy equipment market share

North America holds a substantial position in the global phototherapy equipment market and is expected to hold most of the market share. The rising incidence of skin diseases, including psoriasis, eczema, and vitiligo, is a major driver for the phototherapy equipment market in North America. As more individuals seek effective treatment options for these conditions, the demand for advanced phototherapy solutions continues to grow. Increased awareness and improved diagnosis of these disorders contribute to higher treatment rates, further boosting market demand.

Neonatal jaundice is a common condition among newborns that leads to increased demand for phototherapy devices specifically designed to manage this issue. Phototherapy has become a standard treatment option in hospitals and clinics across the region due to its effectiveness in reducing bilirubin levels in infants. The consistent need for these treatments ensures a steady market for phototherapy equipment.

Technological innovations in phototherapy equipment, particularly the development of LED-based systems, have significantly improved treatment efficacy and safety. These advancements include features such as remote monitoring and adjustable light intensity, which enhance patient care and convenience. As healthcare providers increasingly adopt these advanced technologies, the market for phototherapy equipment expands.

Furthermore, in this region, a major number of key players present, well-advanced healthcare infrastructure, and innovative product launches that would drive this global phototherapy equipment market growth. For instance, in June 2023, GlobalMed Technologies (GMT) unveiled a new line of topical skincare products designed to enhance the effectiveness of its clinically proven LED light therapy treatments, specifically the Omnilux Contour Face and Omnilux Men. This launch highlights GMT's dedication to innovation in the field of aesthetic dermatology. Thus, the above factors are consolidating the region's position as a dominant force in the global phototherapy equipment market.

Asia Pacific is growing at the fastest pace in the global phototherapy equipment market share

Asia Pacific holds the fastest pace in the global phototherapy equipment market and is expected to hold most of the market share. The increasing prevalence of skin conditions such as psoriasis and eczema are a significant catalyst for the phototherapy equipment market in Asia-Pacific. Growing awareness of these disorders has led more individuals to seek effective treatment options, thereby boosting demand for advanced phototherapy solutions.

Neonatal jaundice remains a common condition among newborns, leading to heightened demand for specialized phototherapy devices. The effectiveness of phototherapy in lowering bilirubin levels has made it a standard treatment in hospitals and clinics throughout the region. The growing geriatric demographic in countries like Japan and South Korea is contributing to the demand for phototherapy devices. Older adults are more susceptible to skin conditions requiring treatment, creating a significant market opportunity for manufacturers.

Innovations in technology, particularly the emergence of LED-based systems, have notably improved the efficacy and safety of phototherapy devices. Features such as remote monitoring and adjustable light intensity enhance patient care and convenience, further encouraging the adoption of these advanced technologies.

Furthermore, key players in the industry initiatives and government-supportive activities would drive this global phototherapy equipment market growth. For instance, in October 2024, the recent inauguration of new healthcare facilities at the All-India Institute of Medical Sciences (AIIMS)-Patna, including the expansion of its neonatal intensive care unit (NICU) from eight to 24 beds, highlights the increasing demand for advanced healthcare solutions.

This demand is particularly evident in the phototherapy equipment market, which is experiencing substantial growth due to rising cases of neonatal jaundice and skin disorders that phototherapy effectively addresses. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global phototherapy equipment market.

Competitive Landscape

The major global players in the phototherapy equipment market include GE Healthcare, Philips, Natus Medical Incorporated, Phoenix Medical Systems., Atom Medical Corp., Nice Neotech Medical Systems Pvt. Ltd., NatBio., Solarc Systems Inc., The Daavlin Company, and MTTS. among others.

Key Developments

  • In March 2024, Celluma Light Therapy unveiled the Celluma CONTOUR, an innovative body contouring device that has gained significant attention for being the first LED light therapy system to receive FDA clearance for over-the-counter body contouring. This milestone represents a major advancement in non-invasive aesthetic treatments, offering consumers an effective and accessible option for body sculpting.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global phototherapy equipment market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Radiation Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Phototherapy Technology
    • 4.1.2. Restraints
      • 4.1.2.1. Risk Factors Associated with the Treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Conventional Phototherapy Equipment*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Full-body Phototherapy Equipment
    • 6.2.4. Partial-body Phototherapy Equipment
    • 6.2.5. Conventional Phototherapy Equipment with Fluorescent Lamp
    • 6.2.6. Conventional Phototherapy Equipment with Compact Fluorescent Lamp
  • 6.3. LED Phototherapy Equipment
  • 6.4. Fiberoptic Phototherapy Equipment
  • 6.5. Germicidal Lamps
  • 6.6. Accessories

7. By Radiation Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 7.1.2. Market Attractiveness Index, By Radiation Type
  • 7.2. UVA (Ultraviolet A*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. UVB (Ultraviolet B)
  • 7.4. UVC (Ultraviolet C)

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Skin Disease Treatment*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Psoriasis
    • 8.2.4. Eczema
    • 8.2.5. Vitiligo
    • 8.2.6. Acne
    • 8.2.7. Others
  • 8.3. Neonatal Jaundice Management

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Specialty Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dermatology Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Philips
  • 12.3. Natus Medical Incorporated
  • 12.4. Phoenix Medical Systems.
  • 12.5. Atom Medical Corp.
  • 12.6. Nice Neotech Medical Systems Pvt. Ltd.
  • 12.7. NatBio.
  • 12.8. Solarc Systems Inc.
  • 12.9. The Daavlin Company
  • 12.10. MTTS.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us